Physician profile
Sylvester Odeke
NPI 1265426787
$624.29
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.69 · 2021: $83.06 · 2023: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $243.99 | 2023 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Corcept Therapeutics | $83.06 | 2021 | |
| Dexcom, INC. | $69.71 | 2023 | Dexcom G7 Gss (161) |
| Xeris Pharmaceuticals, INC. | $59.08 | 2023 | Gvoke Hypopen |
| Lilly USA, LLC | $42.81 | 2023 | Jardiance, Humulin, Mounjaro |
| Novo Nordisk INC | $36.62 | 2023 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.25 | 2023 | Jardiance |
| Ultragenyx Pharmaceutical INC. | $19.18 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.66 | 2023 | Strensiq |
| Esperion Therapeutics, INC. | $16.24 | 2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $15.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvester Odeke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.